WHO Endorses Twice-Yearly Injectable Lenacapavir for HIV Prevention

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

Written & Supervised By
Preventive Medicine and Public Health Specialist | 40+ Years Experience

Medically Reviewed
Dr. Jose Rossello, MD, PhD, MHCM
Preventive Medicine & Public Health Specialist
Last Reviewed: September 23, 2025

The World Health Organization now recommends injectable lenacapavir as a twice-yearly option for HIV prevention, providing a highly effective alternative to daily oral pills. This long-acting injectable can improve adherence and access, especially for people facing challenges with daily medication, stigma, or healthcare access. Its use could significantly enhance HIV prevention efforts globally, particularly in high-risk populations.

Source: Who Releases

🏛️ Read official report[1]

Date: September 23, 2025

  1. Tertiary Prevention in Preventive Medicine: Strategies for Managing Chronic Disease
  2. Secondary Prevention in Preventive Medicine: Strategies for Disease Control and Management
  3. Preventive Genomics and Personalized Medicine

References

  1. WHO recommends injectable lenacapavir for HIV prevention. Accessed November 8, 2025
author avatar
Jose Rossello, MD, PhD, MHCM
Dr. Rossello is a medical doctor specializing in Preventive Medicine and Public Health. He founded PreventiveMedicineDaily.com to provide evidence-based health information supported by authoritative medical research.
See Full Bio
Previous
Next
Leave a Comment

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}